These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25616644)

  • 1. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.
    Jackson CE; Castagno D; Maggioni AP; Køber L; Squire IB; Swedberg K; Andersson B; Richards AM; Bayes-Genis A; Tribouilloy C; Dobson J; Ariti CA; Poppe KK; Earle N; Whalley G; Pocock SJ; Doughty RN; McMurray JJ;
    Eur Heart J; 2015 May; 36(18):1106-14. PubMed ID: 25616644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.
    Berry C; Poppe KK; Gamble GD; Earle NJ; Ezekowitz JA; Squire IB; McMurray JJV; McAlister FA; Komajda M; Swedberg K; Maggioni AP; Ahmed A; Whalley GA; Doughty RN; Tarantini L;
    QJM; 2016 Jun; 109(6):377-382. PubMed ID: 25979270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
    Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
    Eur Heart J; 2012 Jul; 33(14):1750-7. PubMed ID: 21821849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
    Simpson J; Castagno D; Doughty RN; Poppe KK; Earle N; Squire I; Richards M; Andersson B; Ezekowitz JA; Komajda M; Petrie MC; McAlister FA; Gamble GD; Whalley GA; McMurray JJ;
    Eur J Heart Fail; 2015 Nov; 17(11):1182-91. PubMed ID: 26358762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report.
    Poppe KK; Squire IB; Whalley GA; Køber L; McAlister FA; McMurray JJ; Pocock S; Earle NJ; Berry C; Doughty RN;
    Eur J Heart Fail; 2013 Nov; 15(11):1220-7. PubMed ID: 23803952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
    Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.
    Yoshihisa A; Sato Y; Kanno Y; Takiguchi M; Yokokawa T; Abe S; Misaka T; Sato T; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Takeishi Y
    Open Heart; 2020; 7(1):e001112. PubMed ID: 32341787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
    Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
    ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes.
    Basuray A; French B; Ky B; Vorovich E; Olt C; Sweitzer NK; Cappola TP; Fang JC
    Circulation; 2014 Jun; 129(23):2380-7. PubMed ID: 24799515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data.
    Padwal R; McAlister FA; McMurray JJ; Cowie MR; Rich M; Pocock S; Swedberg K; Maggioni A; Gamble G; Ariti C; Earle N; Whalley G; Poppe KK; Doughty RN; Bayes-Genis A;
    Int J Obes (Lond); 2014 Aug; 38(8):1110-4. PubMed ID: 24173404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with heart failure with preserved ejection fraction.
    Poppe KK; Doughty RN
    Heart Fail Clin; 2014 Jul; 10(3):503-10. PubMed ID: 24975912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction.
    van Diepen S; Chen AY; Wang TY; Alexander KP; Ezekowitz JA; Peterson ED; Roe MT
    Am Heart J; 2014 Feb; 167(2):267-273.e1. PubMed ID: 24439989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does treatment improve prognosis of heart failure with preserved ejection fraction?].
    Schläpfer-Pessina A; Carballo S; Perrier A; Garin N
    Rev Med Suisse; 2015 Jan; 11(458):199-205. PubMed ID: 25831613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis.
    Shah RV; Desai AS; Givertz MM
    J Card Fail; 2010 Mar; 16(3):260-7. PubMed ID: 20206902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.